Alumni Ventures Group

TAU Systems develops compact particle accelerators, including advanced laser-based systems and specialized X-ray free-electron lasers. These innovations enable researchers, manufacturers, and medical developers to conduct faster experimentation and accelerate innovation across various scientific and industrial fields.

Salvo Health is a specialty care provider operating an app-based virtual clinic focused on managing chronic gut conditions. The company improves access to advanced healthcare by employing its proprietary Whole Self Science model, which considers overall health and contributing factors beyond the gut to pinpoint underlying causes and offer individualized, ongoing treatment strategies for patients with chronic gastrointestinal issues.

Springbok Analytics offers an AI-powered software platform that transforms MRIs into three-dimensional analyses of muscle to enable true precision. Springbok Analytics' advanced imaging technology identifies and measures each individual muscle, providing data to scientists, physical therapists, athletic trainers, and physicians to evaluate muscle function in relation to performance and injury management. The technology has numerous applications, including injury management, performance enhancement, and the treatment of musculoskeletal conditions.

Precision Neuroscience is a New York-based neurotechnology company developing a next-generation brain–computer interface platform to enable breakthrough treatments for neurological illnesses affecting billions worldwide. The company aims to deliver minimally invasive, safely removable implants capable of processing large amounts of neural data across multiple brain regions to support therapeutic interventions. Founded in 2021, it focuses on translating neural signals into clinical outcomes, with technology described as a thin-film microelectrode array that conforms to the brain surface without penetrating tissue, enabling broad neural data collection to aid treatment of spinal cord injuries, stroke, and neurodegenerative diseases.

MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).

Lōvu Health is a digital health company specializing in maternal care. It provides a platform that supports mothers and babies from conception through to postpartum, using AI to deliver real-time analytics and evidence-based insights. The platform monitors vital signs like fetal heart rate and blood pressure, offers personalized recommendations, and sends action-oriented alerts, empowering users with reliable information and expert knowledge.

Canid is a healthcare technology company that focuses on pediatric vaccination workflows. It provides a healthcare dashboard and process tool to simplify vaccination record management, automate vaccine workflow, and oversee vaccine inventory. The platform includes a scanning system that eliminates manual data entry by capturing vaccine information and uploading it to state immunization registries, reducing administrative tasks for pediatric practitioners. It also offers administrative consulting and helps secure vaccine margins, supporting efficient practice operations for clinicians while giving state officials clearer oversight of vaccination programs.

Andromeda Surgical develops autonomous robotic systems aimed at enhancing surgical precision, consistency, and efficiency.

CytoVale is a medical technology company based in San Francisco that develops biomarkers derived from the mechanical properties of single cells. The company uses microfluidics to route and probe cells, enabling the measurement of multiple biophysical indicators at once. Its technology aims to advance early detection of immune-mediated diseases and sepsis through the analysis of cell mechanics and machine learning. By translating biophysical signals into diagnostic information, CytoVale seeks to improve diagnostic accuracy, support timely treatment decisions, and reduce healthcare costs.

Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.

Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.

Syntra develops an EHR platform that streamlines billing, records, and follow-ups, helping doctors automate tasks.

GC Therapeutics employs synthetic biology to transform patient-derived stem cells into diverse cell types efficiently and at scale. The company has validated its technology across multiple applications, creating SuperCells™ tailored for specific conditions. Originally developed in Professor George Church's lab at Harvard Medical School, GC Therapeutics is dedicated to bringing this innovative method to patients.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

InGel Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company focuses on developing engineered cell therapies aimed at targeting neuroprotective pathways to address retinal degeneration. Utilizing stem cells and their secretome, InGel Therapeutics aims to provide neuroprotection for blinding diseases such as retinitis pigmentosa and macular degeneration. The company leverages biodegradable polymers to isolate neuroprotective proteins, initially testing these solutions in vitro before advancing to in vivo applications. Through its innovative approach, InGel Therapeutics seeks to enable healthcare professionals to more effectively treat patients suffering from retinal degeneration.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

Hopscotch Primary Care is a healthcare company focused on transforming rural healthcare through data-driven, team-based care that expands access and improves quality for patients in rural communities. The organization delivers tailored quality care via a collaborative model and provides resources and support for patients inside and outside clinics, enabling clinicians to offer the right care and continuity of service.

Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.

Leo Cancer Care develops an integrated cancer treatment system designed to simplify radiation therapy and improve patient experience. Founded in Australia, the company promotes upright patient positioning and a shift from machine rotation to patient rotation, supported by global research on its clinical benefits. The system combines three-dimensional imaging with automated control of radiation beams to deliver the appropriate energy to the targeted tissue, enabling radiotherapy centers to reduce pain, time, and cost. It can be integrated with standard radiotherapy equipment to support image-guided delivery and streamlined workflows. By prioritizing patient positioning and precise dose delivery, Leo Cancer Care aims to improve treatment accuracy, accessibility, and safety in cancer care.

Founded in 2016, Bionaut Labs specializes in developing intra-tissue navigation platforms using micro-robots for precise anatomical targeting. Its innovative technology enables remote-controlled delivery of therapeutics to challenging clinical settings, revolutionizing the treatment of central nervous system disorders and other diseases.

Nectero Medical is a clinical-stage biotechnology company based in Dover, Delaware, founded in 2017. The company is focused on developing a novel treatment aimed at stabilizing the growth of mid-sized abdominal aortic aneurysms and preventing their rupture. Nectero Medical's innovative approach involves delivering a compound with a stabilizing agent directly to the aneurysm site, which inhibits further breakdown of the vessel wall and strengthens it. This treatment enables patients to undergo earlier intervention safely, potentially delaying or eliminating the need for major endovascular or surgical repairs.

HelixNano is a biotechnology startup that employs artificial intelligence and synthetic biology to develop innovative treatments for genetic diseases. Founded with backing from Y Combinator and venture capitalists, the company initially focused on creating cancer vaccines over two years. Currently, HelixNano is adapting its technology to combat COVID-19, aiming to produce precise and safe vaccine candidates. Its long-term goal is to develop a universal coronavirus vaccine that protects against future outbreaks.

Nest Health is a family healthcare platform that brings medical services to the home through in-home and virtual visits. It serves patients across newborns, children, teens, and adults with a wide range of services including medical, behavioral health, and nutrition support, as well as preventive care, sick visits, and chronic disease management. The company aims to reduce the burden of arranging care by enabling patients to receive necessary treatments and consultations without leaving home, delivering convenient and accessible care in the familiar setting of the home.

BE Therapeutics is a biotechnology company specializing in regenerative medicine. It develops innovative therapies aimed at repairing and restoring damaged brain and spinal cord tissue, with the goal of improving patient outcomes for neurological conditions and spinal cord injuries. The company's approach involves engineering functional tissue to replace or repair damaged structures, offering a novel solution in healthcare.

Founded in 2014, Cyrus Biotechnology develops software tools for accelerating basic research in biotech, pharma, and industrial biotechnology. Its flagship product, Cyrus Bench, offers an enterprise version of the Rosetta molecular modeling and design toolkit along with associated bio-molecular computation tools.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Pendulum Therapeutics is a biotechnology company specializing in microbiome-targeted therapies. Founded in 2013 by experts in microbiology, biochemistry, computational science, and clinical research, the company develops evidence-based medical probiotics to manage chronic illnesses, with a focus on type 2 diabetes. Its flagship product, Pendulum Glucose Control, has demonstrated efficacy in lowering blood sugar spikes and reducing A1C levels in clinical trials.

Piction Health is a company focused on enhancing access to dermatology care for patients experiencing skin, hair, or nail issues. The company offers a dermatology care application that allows patients to receive expert consultations from dermatologists within two days, including a diagnosis and personalized care plan. By leveraging artificial intelligence, Piction Health streamlines the diagnostic process for both patients and primary care providers, enabling quicker assessments of complex skin conditions. The application provides immediate second opinions, allowing primary care providers to efficiently address challenging skin diseases, thereby saving time and reducing costs associated with unnecessary repeat visits and ineffective treatments. Piction Health aims to ensure that high-quality dermatological care is accessible from the comfort of home, ultimately improving patient outcomes.

Granata Bio is a biotechnology company established in 2018 that specializes in identifying and developing therapeutics for fertility patients. The company focuses on creating a comprehensive portfolio of fertility-related treatments and leverages its expertise in commercialization, late-stage clinical trials, and regulatory development. Granata Bio aims to address significant challenges faced by medical professionals in fertility treatment. Recently, the company announced a partnership with IBSA Institut Biochimique to co-develop a novel subcutaneous progesterone solution, further enhancing its commitment to improving fertility care.

Earli is a biotechnology company focused on advancing cancer detection and treatment through innovative technology. The company specializes in developing devices that utilize a novel gene therapy approach known as Synthetic Biopsy. This method compels cancer cells to produce synthetic biomarkers, which are not naturally occurring in the human body. These biomarkers can then be detected in bodily fluids such as blood, urine, or breath, allowing for early identification of cancer. By facilitating the early detection of homogeneous tumors, Earli aims to significantly improve the chances of successful treatment and personalize therapy options for patients. Additionally, the technology is designed to be visible during imaging procedures such as PET scans, enhancing the monitoring of cancer progression and treatment efficacy.

DocStation, Inc. is a cloud-based patient care platform headquartered in Austin, Texas, that was established in 2017. The company focuses on connecting payers and pharmacists to facilitate value-based care programs, which aim to reduce healthcare costs and enhance patient outcomes. Its platform equips pharmacists with essential tools, including a comprehensive dashboard that consolidates patient information such as diagnoses, medications, immunizations, allergies, and adverse events. This integration allows pharmacists to create care plans, set goals, monitor patient adherence, and schedule follow-ups, thereby enabling real-time connections with patients. With over 500 providers collaborating with innovative health plans on the platform, DocStation is positioned to transform the pharmacy landscape by aligning the interests of all stakeholders involved in patient care.

CytoVale is a medical technology company based in San Francisco that develops biomarkers derived from the mechanical properties of single cells. The company uses microfluidics to route and probe cells, enabling the measurement of multiple biophysical indicators at once. Its technology aims to advance early detection of immune-mediated diseases and sepsis through the analysis of cell mechanics and machine learning. By translating biophysical signals into diagnostic information, CytoVale seeks to improve diagnostic accuracy, support timely treatment decisions, and reduce healthcare costs.

Eigen Therapeutics is a biotechnology company dedicated to advancing cancer treatment through the development of innovative therapies. It specializes in "priming" therapies that enhance the effectiveness of targeted treatments by addressing cancer heterogeneity, which makes cancer cells more susceptible to therapeutic interventions while simultaneously protecting healthy cells. Eigen is creating a high-throughput discovery platform that integrates proprietary machine learning algorithms to identify novel drug classes and therapeutic approaches capable of altering a cell’s state to increase vulnerability to treatments. This platform combines biology and engineering, utilizing in-house developed robotic systems, laboratory operations software, and machine learning analysis pipelines. The company's mission focuses on improving patient outcomes by providing novel combination therapeutics that enhance efficacy and reduce toxicity in cancer care, ultimately aiming to meet significant medical needs in oncology.

Canid is a healthcare technology company that focuses on pediatric vaccination workflows. It provides a healthcare dashboard and process tool to simplify vaccination record management, automate vaccine workflow, and oversee vaccine inventory. The platform includes a scanning system that eliminates manual data entry by capturing vaccine information and uploading it to state immunization registries, reducing administrative tasks for pediatric practitioners. It also offers administrative consulting and helps secure vaccine margins, supporting efficient practice operations for clinicians while giving state officials clearer oversight of vaccination programs.

PulzAid is a managed marketplace focused on providing healthcare services to injured workers. It facilitates access to telehealth, mobile imaging, specialists, and diagnostic services through its specialized software and established relationships with orthopedic surgeons and occupational medicine doctors. By offering on-demand video consultations, in-person nurse visits, lab testing, and prescription services, PulzAid aims to expedite the treatment process for employees, enabling them to return to work more quickly and in better health. The company's approach not only addresses workplace injuries but also seeks to reduce associated costs and liabilities for employers, particularly in managing workers' compensation claims.

TFC Therapeutics is a biotechnology company focused on creating innovative biologics aimed at addressing critical factors in cancer recurrence and metastasis. The company develops technology that employs monoclonal antibodies designed to specifically bind to receptors on tumor-initiating cells, known as TMH cells. This targeted approach activates the immune system to effectively destroy these cells, offering new treatment possibilities for cancer within the healthcare sector. Through its research and development efforts, TFC Therapeutics seeks to contribute significantly to advancements in cancer therapy.

Founded in 2013 by Dr. Hany Kurdi, Dentologie revolutionizes the dental experience by creating safe, inclusive spaces that combine compassionate care, clinical expertise, and innovative design. Headquartered in Chicago, Illinois, the company offers a comprehensive range of services including general dentistry, Invisalign treatment, oral surgery, and cosmetic dentistry.

Ossium Health, Inc. is a biotechnology company that specializes in developing and manufacturing advanced cell therapy products aimed at treating blood cancers, improving organ transplantation, and repairing tissue damage caused by radiation exposure. Established in 2016 and based in San Francisco, the company has created a range of therapies, including HPC, Marrow, which consists of human leukocyte antigen (HLA)-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients. Additionally, Ossium offers Chimera, designed to enhance organ transplantation, and Chymalis, which utilizes mesenchymal stem cells from bone marrow to facilitate the healing of damaged bone and muscle tissue. The company also supplies bone marrow cells for research in oncology, immunology, and related fields, focusing on improving health and longevity through innovative bioengineering techniques.

Upside Health, Inc. is a healthcare technology company based in New York, founded in 2017, that focuses on chronic pain management through its innovative mobile application, Ouchie. This application provides patients with targeted educational content and rewards for achieving functional milestones, fostering a supportive community for individuals managing chronic pain. Upside Health's platform includes remote patient monitoring and engagement tools that enable clinicians to access valuable data, improving care outcomes while minimizing additional burdens on healthcare providers. By empowering both patients and clinicians, Upside Health aims to transform the assessment and treatment of chronic pain, ultimately enhancing the quality of care and reducing healthcare costs.

3X Genetics is a company focused on developing medical screening solutions aimed at identifying genetic disorders, particularly in infants and children. The company has created innovative technologies that allow for proactive screening of the population for conditions such as myotonic dystrophy and other trinucleotide repeat issues associated with progressive muscle weakness. By enabling healthcare professionals to detect these genetic disorders early, 3X Genetics plays a crucial role in preventing the birth of children affected by serious genetic diseases.

MedScout is a revenue acceleration platform tailored for medical device and diagnostic companies. It offers a sales enablement software that integrates medical claims intelligence from both public and private payors, providing a user-friendly interface specifically designed for sales professionals and leaders. The platform delivers immediate insights into the addressable market within existing territories and facilitates understanding of market dynamics. By supplying comprehensive information on patient demographics, procedure volumes, referral patterns, and payment data, MedScout empowers its clients to optimize their sales strategies and enhance operational productivity, ultimately driving growth in the life sciences sector.

Oliva Therapy is an online mental healthcare platform based in Barcelona, Spain, founded in 2020. It aims to make mental healthcare accessible, uncomplicated, and stigma-free for busy individuals. The platform allows users to book one-hour therapy sessions via real-time video calls with expert-curated therapists, who are matched to users based on their specific needs. By simplifying the process of seeking therapy, Oliva helps working professionals achieve their mental health goals while maintaining a better work-life balance. The focus on personalized matching and a hassle-free online experience distinguishes Oliva in the mental health sector.

Pharmacy Marts is an online business-to-business marketplace that connects pharmacists with multiple suppliers to source daily prescriptions and pharmacy supplies. Founded in 2021 and based in Cairo, Egypt, the platform combines fintech and logistics features to offer discounts on medications from various warehouses, with no delivery charges for orders. It enables medical suppliers to list products and allows pharmacists to compare offers in a single location to fulfill daily supply requests.

Andromeda Surgical develops autonomous robotic systems aimed at enhancing surgical precision, consistency, and efficiency.

Mign is a company focused on revolutionizing the design and production of personalized medical devices for musculoskeletal health. It specializes in developing digital solutions for orthopedic products, utilizing proprietary technology that synthesizes complex three-dimensional body data. This approach allows Mign to create custom wearables tailored to individual physical requirements, featuring breathable three-dimensional patterns that enhance comfort and functionality. By integrating advanced design tools and a commitment to sustainability, Mign aims to improve patient outcomes in orthopedic care through innovative and personalized solutions.

Bionic Health specializes in digital healthcare, focusing on preventative health services for individuals with chronic pain. The company's platform offers frequent diagnostics and employs machine learning to create customized treatment plans, aiming to slow down aging and provide personalized insights for patients.

Dimension Inx designs and develops advanced biomaterials for regenerative medicine. Founded in 2017, it specializes in creating microenvironments that guide the body's natural healing processes. Its platform focuses on the interplay between material composition, microstructure, and microarchitecture to produce biofunctional materials.

Precision Neuroscience is a New York-based neurotechnology company developing a next-generation brain–computer interface platform to enable breakthrough treatments for neurological illnesses affecting billions worldwide. The company aims to deliver minimally invasive, safely removable implants capable of processing large amounts of neural data across multiple brain regions to support therapeutic interventions. Founded in 2021, it focuses on translating neural signals into clinical outcomes, with technology described as a thin-film microelectrode array that conforms to the brain surface without penetrating tissue, enabling broad neural data collection to aid treatment of spinal cord injuries, stroke, and neurodegenerative diseases.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, focused on developing innovative psychotropic drugs to address mental health issues. Founded in 2019, the company specializes in creating novel compounds that enhance the benefits of traditional psychedelics, improving parameters such as safety, tolerability, duration, and efficacy. Gilgamesh targets a range of neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. With the growing global mental health crisis, the company aims to accelerate the development of new treatments that meet the urgent need for effective solutions in mental health care, leveraging its expertise in medicinal chemistry and drug development.

Eigen Therapeutics is a biotechnology company dedicated to advancing cancer treatment through the development of innovative therapies. It specializes in "priming" therapies that enhance the effectiveness of targeted treatments by addressing cancer heterogeneity, which makes cancer cells more susceptible to therapeutic interventions while simultaneously protecting healthy cells. Eigen is creating a high-throughput discovery platform that integrates proprietary machine learning algorithms to identify novel drug classes and therapeutic approaches capable of altering a cell’s state to increase vulnerability to treatments. This platform combines biology and engineering, utilizing in-house developed robotic systems, laboratory operations software, and machine learning analysis pipelines. The company's mission focuses on improving patient outcomes by providing novel combination therapeutics that enhance efficacy and reduce toxicity in cancer care, ultimately aiming to meet significant medical needs in oncology.

SendaRide, Inc. is a transportation service provider focused on non-emergency medical transportation for patients, particularly the elderly and children. Founded in 2016 and headquartered in Oklahoma City, the company operates a platform that allows users to find and book both on-demand and pre-scheduled rides. SendaRide's application offers customized transportation solutions tailored to the healthcare industry, facilitating safe and reliable transport for users. Additionally, the platform includes features such as GPS monitoring and live video feeds, allowing users to track their drivers or caretakers during transit. Users can also rate their experiences, enhancing service accountability and quality.

Brave Health is a virtual clinic that provides telehealth services focused on mental health and addiction treatment. Established in 2017 by Anna Lindow in Miami, Florida, the company specializes in behavioral health, offering a range of services including counseling, therapy, psychiatry, and medication management. This includes medication-assisted treatment, allowing patients to receive comprehensive care for various conditions related to mental health and substance use disorders. By leveraging telehealth technology, Brave Health enables patients to access essential services conveniently and efficiently, addressing the growing need for accessible mental health care.

Founded in 2021, Koala Health simplifies pet care by providing medications and health products through its digital platform. It offers features such as prescription management, date-and-time-based packaging, and free delivery.

Remedial Health is a company focused on enhancing the procurement and distribution of pharmaceuticals across Africa. It provides a platform that facilitates business-to-business access to medicines, enabling pharmacies and hospitals to order and access retail medications directly from manufacturers or distributors. This approach addresses the inefficiencies and risks associated with relying on open-air medicine markets, where healthcare providers often encounter counterfeit products. By improving the pharmacy operations and workflow management processes, Remedial Health aims to ensure that healthcare providers can more effectively stock their facilities, thereby contributing to a safer and more reliable healthcare environment.

Nanopath is a molecular diagnostics company that develops innovative platforms for rapid disease diagnosis. Its technology enables point-of-care testing, eliminating the need for nucleic acid amplification and supporting multiplexed detection. This allows patients and healthcare providers to access accurate diagnostic results within standard office visits, improving healthcare outcomes.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

Magnetic Insight, Inc. is a company specializing in magnetic particle imaging (MPI), an innovative imaging modality that detects iron oxide nanoparticle tracers through time-varying magnetic fields. Founded in 2012 and headquartered in Alameda, California, the company offers several key products, including the MOMENTUM imager, a pre-clinical MPI solution designed to produce high-quality images using advanced magnetic field gradients and proprietary reconstruction processes. Additionally, Magnetic Insight develops VivoTrax, a nanoparticle for cell tracking and as a blood pool agent, and Hyper, an add-on module for the MOMENTUM system that facilitates targeted magnetic hyperthermia treatment. The company's technology enables real-time monitoring of biological events, making significant strides in areas such as quantitative cell tracking, imaging of vascular function, and research into regenerative medicine and CAR-T cell therapies.

Boulder Care, established in 2017 and headquartered in Portland, Oregon, specializes in telemedicine-based programs for opioid addiction treatment. The company offers comprehensive services including medication-assisted treatment with buprenorphine, peer support, patient counseling, and psychosocial services to aid recovery. Boulder Care serves patients directly, as well as healthcare providers and organizations seeking to expand access to effective opioid addiction treatment.

Quadrant Health is a health technology company that provides a cloud-based analytics platform for healthcare providers to analyze electronic health records and patient messaging data in real time. The platform uses machine learning to identify potential health risks and to predict infections, injuries, and other harms before symptoms appear, enabling proactive patient care and support for preventive medicine.

Pharmacy Marts is an online business-to-business marketplace that connects pharmacists with multiple suppliers to source daily prescriptions and pharmacy supplies. Founded in 2021 and based in Cairo, Egypt, the platform combines fintech and logistics features to offer discounts on medications from various warehouses, with no delivery charges for orders. It enables medical suppliers to list products and allows pharmacists to compare offers in a single location to fulfill daily supply requests.

NeuraLight is a venture-backed company dedicated to improving the lives of billions affected by neurological disorders. It develops a digital neurology platform that uses smartphone or webcam technology to accurately assess and monitor patients, enabling better evaluation and care.

Seaspire Skincare specializes in developing multifunctional colorants and actives inspired by ocean biodiversity. Its flagship product, Xanthochrome, offers broader UV protection and aims to replace harmful ingredients in skincare products, promoting sustainability and reduced adverse effects on human and marine health.

Curbside Health develops clinical decision support software that aligns health systems and clinicians to more efficiently deliver optimal care. The company was founded by physicians and technologists to combine the best of clinical evidence with the realities of healthcare delivery and with opportunities of modern web technology. We support health systems and hospitals to expand their clinical content library (e.g. clinical pathways, protocols, guidelines, A3s, checklists, etc) and enhance the utilization of these resources at the point-of-care. Together, the components of Curbside's platform enable a hospital to improve clinical outcomes and operational efficiencies. Product development is informed by working closely with patients, clinicians, engineers, physicians, healthcare administrators, and payors. Our mission is hiding in plain sight within our name, and those in healthcare will understand: every medical decision is informed in real-time by the world's expert of that particular situation, while simultaneously accounting for hospital policy and all relevant patient-specific data. Essentially, Curbside is on a never-ending quest to perfect medical decision making.

Iterative Scopes, Inc. is a Boston-based company established in 2017 that specializes in developing machine learning-powered diagnostic tools aimed at assisting gastroenterologists in the prevention of colon cancer. The company focuses on providing innovative solutions for physicians and life sciences professionals within the colorectal cancer and inflammatory bowel disease sectors. By leveraging advanced technology, Iterative Scopes aims to enhance diagnostic accuracy and improve patient outcomes in these critical areas of healthcare.

Hey Jane is a telehealth startup that connects patients to healthcare providers that offer online medical consultations. The company's innovative Complete Care model utilizes technology for unparalleled layers of support: medical, emotional, and social. Since 2021, Hey Jane has helped nearly 20,000 patients get the care they need. And this is only the beginning; soon, we will reimagine care for even more common but underserved treatments, with the ultimate goal of becoming the most trusted healthcare company out there—one that pushes the boundaries of access with convenient, inclusive, and patient-driven care.

Founded in 2015, Luma Health develops a patient engagement platform that connects healthcare providers with patients via smart scheduling, appointment reminders, mobile intake, and care pathways. Its platform integrates with EHR systems for insights and analytics.

Insiteflow provides an EHR integrated platform that supports clinical decision solutions and optimizes clinical workflows. The platform delivers point-of-care insights to improve decision making and treatment planning. It deploys automated EHR workflows to boost user adoption, efficiency and effectiveness, and features patent-pending technology. The system writes clinicians' and staff decisions into EHR databases to enable improvements at key decision points in care. Founded in 2018 in Austin, Texas by Anthony Gerardi and Corey Hall.

Cellibre, Inc. is a cellular agriculture company founded in 2017 and headquartered in San Diego, California. The company focuses on transforming cells into specialized, sustainable factories to produce significant biological products at scale. Employing an organism-agnostic approach, Cellibre develops natural medicines by leveraging the naturopathic therapies of various cultures, as well as utilizing resources from plants, animals, insects, and marine life. This innovative method enables the healthcare industry to produce cannabinoid-based medicines aimed at providing efficient treatment options.

Gordy Health is a virtual care provider based in Pasadena, California, founded in 2021. The company specializes in blood pressure management to reduce patients' risk of heart attack, stroke, and kidney failure. Gordy Health offers a healthcare platform that allows users to manage their blood pressure from home, with features including direct access to heart specialists, easy-to-schedule virtual appointments, real-time diagnostics, prescription delivery, and ongoing monitoring and medication adjustments. The goal is to prevent complications from high blood pressure, helping patients achieve healthier lives and increased longevity.

Evernow offers comprehensive women's healthcare services focused on menopause. Their platform provides online access to specialized doctors, evidence-based information, treatments, and supportive communities, empowering women to manage hormonal changes and improve their overall health.

Blue Note Therapeutics is a prescription digital therapeutics company that develops software-driven mental health solutions and collaborates with medical researchers and patient advocacy organizations to provide physician-prescribed therapies accessible on mobile devices. Its platform delivers evidence-based interventions designed to prevent, manage, and treat mental health conditions associated with serious illnesses, including cancer, and can be used as first-line or adjuvant therapies. The company is based in San Francisco, California, and was founded in 2018.

LingoHealth is a digital health platform dedicated to assisting family members in supporting the health of their aging loved ones, particularly within multilingual families. By catering to individuals who speak languages other than English, the platform enhances the caregiving experience by offering resources that are culturally relevant and accessible. LingoHealth empowers family advocates with the necessary tools to navigate the complexities of healthcare, ensuring that their loved ones receive appropriate care and effectively manage their health. The platform addresses the unique challenges faced by immigrant patients and their families, making it easier for them to engage in the care process.

AdaptX is a Seattle-based healthcare technology company established in 2016, spun out from Seattle Children's Hospital. It specializes in data analytics, visualization, and AI for hospitals and surgery centers. The company's core product is a clinical healthcare analytics platform that integrates with institutions' existing electronic data systems. This platform enables medical professionals to monitor, analyze, and improve clinical outcomes and workflows, ultimately enhancing care quality and reducing costs. AdaptX empowers both medical leaders and frontline clinicians to make data-driven decisions, transforming clinical operations within healthcare providers' facilities.

Leo Cancer Care develops an integrated cancer treatment system designed to simplify radiation therapy and improve patient experience. Founded in Australia, the company promotes upright patient positioning and a shift from machine rotation to patient rotation, supported by global research on its clinical benefits. The system combines three-dimensional imaging with automated control of radiation beams to deliver the appropriate energy to the targeted tissue, enabling radiotherapy centers to reduce pain, time, and cost. It can be integrated with standard radiotherapy equipment to support image-guided delivery and streamlined workflows. By prioritizing patient positioning and precise dose delivery, Leo Cancer Care aims to improve treatment accuracy, accessibility, and safety in cancer care.

Leo Cancer Care develops an integrated cancer treatment system designed to simplify radiation therapy and improve patient experience. Founded in Australia, the company promotes upright patient positioning and a shift from machine rotation to patient rotation, supported by global research on its clinical benefits. The system combines three-dimensional imaging with automated control of radiation beams to deliver the appropriate energy to the targeted tissue, enabling radiotherapy centers to reduce pain, time, and cost. It can be integrated with standard radiotherapy equipment to support image-guided delivery and streamlined workflows. By prioritizing patient positioning and precise dose delivery, Leo Cancer Care aims to improve treatment accuracy, accessibility, and safety in cancer care.

Sorcero, Inc. is a technology company founded in 2017 and headquartered in Washington, D.C. It specializes in developing a no-code platform that utilizes artificial intelligence to support decision-making and knowledge management for professionals in STEM fields, particularly in medical, insurance, and engineering industries. The Sorcero Language Intelligence Platform empowers subject matter experts by enabling the deployment of intelligent applications that can analyze and interpret complex data effectively. This platform is designed to enhance various operational processes, such as medical claims investigation, life insurance underwriting, and real-time monitoring of medical guidelines. Sorcero has received notable recognition within the digital health and insurtech sectors, being acknowledged as a leading startup by industry innovation leaders. The company's focus on improving patient outcomes and providing strategic insights through advanced analytics positions it as a significant player in the life sciences and medical analytics landscape.

Founded in 2014, Cyrus Biotechnology develops software tools for accelerating basic research in biotech, pharma, and industrial biotechnology. Its flagship product, Cyrus Bench, offers an enterprise version of the Rosetta molecular modeling and design toolkit along with associated bio-molecular computation tools.

SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.

Veralox Therapeutics specializes in the development of small molecule therapeutics aimed at addressing the underlying pathologies of thrombosis and type one diabetes. The company focuses on innovative treatment paradigms informed by a deep understanding of the molecular mechanisms involved in these diseases. By targeting conditions such as heparin-induced thrombocytopenia and thrombosis, Veralox Therapeutics aims to enhance patient outcomes and facilitate complete recovery from diabetes. Through its research and development efforts, the company seeks to provide effective and transformative therapies for individuals affected by these serious health conditions.

miRecule is a biotechnology company developing targeted RNA therapies for cancer and muscular dystrophy. It uses its proprietary DREAmiR platform to analyze genomic data from thousands of patients, identifying genetic abnormalities and creating tailored RNA therapeutics to directly address these issues.

Founded in 2016, Future Family offers subscription-based fertility care plans. These plans cover all healthcare costs, including personal fertility planning, clinic matching, dedicated nurse concierge services, digital health platforms, and procedures like IVF and egg freezing.

Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York, focused on developing innovative psychotropic drugs to address mental health issues. Founded in 2019, the company specializes in creating novel compounds that enhance the benefits of traditional psychedelics, improving parameters such as safety, tolerability, duration, and efficacy. Gilgamesh targets a range of neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. With the growing global mental health crisis, the company aims to accelerate the development of new treatments that meet the urgent need for effective solutions in mental health care, leveraging its expertise in medicinal chemistry and drug development.

Insiteflow provides an EHR integrated platform that supports clinical decision solutions and optimizes clinical workflows. The platform delivers point-of-care insights to improve decision making and treatment planning. It deploys automated EHR workflows to boost user adoption, efficiency and effectiveness, and features patent-pending technology. The system writes clinicians' and staff decisions into EHR databases to enable improvements at key decision points in care. Founded in 2018 in Austin, Texas by Anthony Gerardi and Corey Hall.

Founded in 2018, Intus Care develops a platform that connects home care providers with patients. Its application uses machine learning to predict hospital readmissions and risks, enabling efficient tracking of care providers and high-risk patient identification.

Scipher Medicine develops a molecular technology platform that predicts patient responsiveness to specific drugs in cardiovascular and autoimmune diseases. Its flagship product, PrismRA, identifies rheumatoid arthritis patients unlikely to respond to anti-TNF therapies, enabling alternative treatments. The company aims to transform drug prescription by predicting optimal therapy using simple blood samples.

InteRNA Technologies B.V. is a biotechnology company focused on developing microRNA (miRNA)-based therapeutics for cancer treatment. Founded in 2006 and headquartered in Nijmegen, the Netherlands, with a research and development center in Utrecht, the company leverages its proprietary technology to discover and validate miRNA sequences that can target multiple signaling pathways involved in cancer initiation, progression, and metastasis. By addressing previously undruggable targets, InteRNA aims to enhance the efficacy of existing cancer therapies and reduce the development of drug resistance. The company employs advanced bioinformatics and massively parallel sequencing techniques to analyze miRNA functions, paving the way for innovative treatment options in oncology.

STIMIT AG is a medtech company based in Nidau, Switzerland, established in 2018. The company specializes in developing innovative therapies and medical devices aimed at patients who have lost their natural breathing function, particularly those on mechanical ventilation. STIMIT's proprietary technology non-invasively activates the body's own diaphragm, which is often weakened in such patients. By strengthening diaphragm function, the company seeks to facilitate the liberation of patients from ventilators, thereby reducing the time spent on ventilation and improving overall patient outcomes. Additionally, STIMIT is working on second-generation therapies that aim to further enhance the inhalation process for patients. Through these advancements, STIMIT is positioned to significantly impact intensive care practices and improve the quality of life for patients with respiratory challenges.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Small Door, Inc., established in 2017 and headquartered in New York, New York, specializes in providing elevated, customer-centric veterinary services with a focus on hospitality. The company aims to enhance the lives of pets and their owners by offering superior care, unmatched transparency, and tech-enabled convenience. Small Door operates 13 veterinary practices across New York City, Boston, and Washington DC, having conducted tens of thousands of member consultations.

SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.

Brio Systems provides a turnkey COVID-19 testing platform for employers, linking laboratories and medical suppliers with workplaces to enable on-site testing. Its platform supports PCR and antibody testing conducted by FDA-certified laboratories, manages logistics for kit distribution and test requisitioning, provides medical oversight, and delivers digital results within about three days of collection. It serves customers across manufacturing, food processing, and other industries, offering a scalable solution that can support up to 50,000 tests daily. Founded in 2017 and based in Boston, Brio Systems focuses on helping employers maintain workforce safety and business continuity through data-driven testing programs.

Better Life Partners Inc. is a healthcare company based in Hanover, New Hampshire, dedicated to providing comprehensive support for individuals struggling with opioid use disorder in the United States. Established in 2018, the company offers a range of services, including medication-assisted treatment, counseling, peer coaching, and group sessions. Better Life Partners focuses on delivering personalized healthcare to vulnerable populations, utilizing technology to create customizable care plans that ensure effective and reliable service delivery. By integrating medical and behavioral healthcare, the company addresses the needs of those affected by addiction, facilitating their recovery through a combination of telehealth, community-based support, and innovative care approaches. With additional offices across New Hampshire, Better Life Partners aims to make a meaningful impact on the lives of individuals seeking to overcome substance abuse challenges.

Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized guidance and support for families caring for aging adults and children. Founded in 2019, the company offers a range of services designed to assist caregivers with various aspects of care, including insurance, finances, legal plans, medical care, home care, housing, daily needs, and overall well-being. Each member of Grayce receives dedicated support from a social worker who helps manage their comprehensive care needs by planning, prioritizing, identifying resources, coordinating care, and advocating on their behalf. Through its social care management platform, Grayce empowers family caregivers to navigate the complexities of caring for vulnerable loved ones.

Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.

Brio Systems provides a turnkey COVID-19 testing platform for employers, linking laboratories and medical suppliers with workplaces to enable on-site testing. Its platform supports PCR and antibody testing conducted by FDA-certified laboratories, manages logistics for kit distribution and test requisitioning, provides medical oversight, and delivers digital results within about three days of collection. It serves customers across manufacturing, food processing, and other industries, offering a scalable solution that can support up to 50,000 tests daily. Founded in 2017 and based in Boston, Brio Systems focuses on helping employers maintain workforce safety and business continuity through data-driven testing programs.

Mission Bio develops and delivers tools for studying cellular heterogeneity in human health and life science research. Its flagship product is the Tapestri Platform, a single-cell platform that detects DNA and protein changes, enabling precise detection of heterogeneity in disease progression and treatment response. The company's solutions are primarily applied in oncology, including blood cancers and solid tumors.

Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Gallant Pet, Inc. is a pet service company based in San Diego, California, that specializes in stem cell preservation services for pets. Founded in 2018 by Aaron Hirschhorn, the company collects and banks stem cells from tissue during routine spay or neuter procedures. Gallant Pet also provides a platelet-rich plasma (PRP) kit for treatment of dogs suffering from osteoarthritis or other musculoskeletal conditions. In addition to its preservation services, Gallant Pet is involved in clinical research to develop effective stem cell therapies for pets. The company's focus on retrieving and preserving regenerative cells allows pet owners to utilize their pets' young stem cells for potential treatments when needed.